Katy Kim1, Mark Zhu2, Alana Cavadino3, Jacob T Munro2, Simon W Young1. 1. Department of Orthopaedics, North Shore Hospital, Auckland, New Zealand. 2. Department of Orthopaedics, Auckland Hospital, Auckland, New Zealand. 3. Section of Epidemiology and Biostatistics, The University of Auckland, Auckland, New Zealand.
Abstract
BACKGROUND: Periprosthetic joint infection (PJI) is the leading cause of early revisions after total knee arthroplasty. Debridement, antibiotics, and implant retention (DAIR) procedures are often the initial treatment for PJI. However, there is concern that failed DAIR undermines the future success of revision procedures. This study aims to investigate the impact of DAIR on the success of subsequent staged revisions for PJI. METHODS: A multicenter retrospective review was performed over a 15-year period. Treatment success was defined as implant retention without the use of long-term suppressive antibiotics. This was compared between patients who underwent a staged revision as the first procedure for PJI (staged-only) and patients who failed DAIR before staged revision (F-DAIR). Competing risk survival analysis was performed to compare the 2 groups and considered for patient demographics, American Society of Anesthesiologists score, organism type, body mass index, age of prosthesis, and duration of symptoms. RESULTS: Of 291 eligible patients, 63 underwent staged revision and 228 underwent DAIR as the first procedure for PJI. Of the 228 DAIR patients, 75 failed DAIR and underwent subsequent staged revision (F-DAIR). At mean follow-up of 6.2 years, the success rate was 72% in the F-DAIR group and 81% in the staged-only group. On survival analysis, there was no significant difference in subdistribution hazard ratio comparing the probability of failure (implant retention) in the 2 treatments groups (subdistribution hazard ratio = 0.72; 95% confidence interval 0.32-1.61; P = .42). CONCLUSION: This study suggested that a previously failed DAIR does not compromise the success rate of a subsequent staged revision.
BACKGROUND: Periprosthetic joint infection (PJI) is the leading cause of early revisions after total knee arthroplasty. Debridement, antibiotics, and implant retention (DAIR) procedures are often the initial treatment for PJI. However, there is concern that failed DAIR undermines the future success of revision procedures. This study aims to investigate the impact of DAIR on the success of subsequent staged revisions for PJI. METHODS: A multicenter retrospective review was performed over a 15-year period. Treatment success was defined as implant retention without the use of long-term suppressive antibiotics. This was compared between patients who underwent a staged revision as the first procedure for PJI (staged-only) and patients who failed DAIR before staged revision (F-DAIR). Competing risk survival analysis was performed to compare the 2 groups and considered for patient demographics, American Society of Anesthesiologists score, organism type, body mass index, age of prosthesis, and duration of symptoms. RESULTS: Of 291 eligible patients, 63 underwent staged revision and 228 underwent DAIR as the first procedure for PJI. Of the 228 DAIR patients, 75 failed DAIR and underwent subsequent staged revision (F-DAIR). At mean follow-up of 6.2 years, the success rate was 72% in the F-DAIR group and 81% in the staged-only group. On survival analysis, there was no significant difference in subdistribution hazard ratio comparing the probability of failure (implant retention) in the 2 treatments groups (subdistribution hazard ratio = 0.72; 95% confidence interval 0.32-1.61; P = .42). CONCLUSION: This study suggested that a previously failed DAIR does not compromise the success rate of a subsequent staged revision.
Authors: Thomas K Fehring; Keith A Fehring; Angela Hewlett; Carlos A Higuera; Jesse E Otero; Aaron J Tande Journal: J Bone Joint Surg Am Date: 2020-07-15 Impact factor: 6.558
Authors: Christopher W Day; Kerry Costi; Susan Pannach; Gerald J Atkins; Jochen G Hofstaetter; Stuart A Callary; Renjy Nelson; Donald W Howie; Lucian B Solomon Journal: J Clin Med Date: 2021-12-27 Impact factor: 4.241
Authors: Joseph K Antonios; Kevin J Bozic; Henry D Clarke; Mark J Spangehl; Joshua S Bingham; Adam J Schwartz Journal: Arthroplast Today Date: 2021-10-05
Authors: Anabelle Visperas; Daniel Santana; Minseon Ju; Nathalie B Milbrandt; Yu Hsin Tsai; Sameera Wickramasinghe; Alison K Klika; Nicolas S Piuzzi; Anna Cristina S Samia; Carlos A Higuera-Rueda Journal: J Bone Jt Infect Date: 2022-04-20
Authors: Anabelle Visperas; Daniel Santana; Alison K Klika; Carlos A Higuera-Rueda; Nicolas S Piuzzi Journal: J Orthop Res Date: 2022-05-06 Impact factor: 3.102